STAAR Surgical Company P/E Ratio 2010–2025
STAAR Surgical Company reported 72.58 of price-to-earnings ratio for fiscal 2023. That was 19.6% higher than fiscal 2022. Compared with fiscal 2018, the change was -75.0%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | — | — |
| FY 2024 | — | — |
| FY 2023 | 72.58 | +19.6% |
| FY 2022 | 60.68 | -62.8% |
| FY 2021 | 163.04 | -80.9% |
| FY 2021 | 854.83 | +662.3% |
| FY 2020 | 112.13 | -61.3% |
| FY 2018 | 290.09 | — |
| FY 2017 | — | — |
| FY 2016 | — | — |
| FY 2016 | — | — |
| FY 2015 | — | — |
| FY 2014 | 1642.00 | — |
| FY 2012 | — | — |
| FY 2011 | 262.25 | — |
| FY 2010 | — | — |
| FY 2010 | — | — |
Source: STAAR Surgical Company SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open STAA 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
STAAR Surgical Company reported 72.58 of price-to-earnings ratio for fiscal 2023. That was 19.6% higher than fiscal 2022. Compared with fiscal 2018, the change was -75.0%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for STAAR Surgical Company
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeSTAAR Surgical Company — frequently asked questions
What is STAAR Surgical Company's price-to-earnings ratio?
STAAR Surgical Company (STAA) reported price-to-earnings ratio of 72.58 for fiscal year 2023, per its SEC filings.
How has STAAR Surgical Company's price-to-earnings ratio changed over time?
Between fiscal 2010 and 2025, STAA's price-to-earnings ratio declined at roughly 8.2% per year (compound annual rate), from 262.25 to 72.58.
Where does this data come from?
Figures are computed from STAAR Surgical Company's official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More STAA financial history
Full STAA fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →